SCHEMBL444581

SCHEMBL444581

Cc1ccc(P(=O)(C(=O)c2c(C)cc(C)cc2C)C(=O)c2c(C)cc(C)cc2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
TSHR P16473 1/20 0.45
HPGD P15428 3/20 0.42
GAA P10253 3/20 0.42
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TAS1R3 Q7RTX0 4/20 0.37
TAS1R1 Q7RTX1 4/20 0.37
TAS1R2 Q8TE23 4/20 0.37
NPSR1 Q6W5P4 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
ALDH1A1 P00352 2/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30038269 0.88 FLT1 (0.38) LMNAHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL15158 0.87 LMNA (0.40) LMNAHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL28310329 0.86 LMNA (0.39) LMNAHPGDKMT2AMEN1SMN1; SMN2
Ammonia Solution, Strong SCHEMBL28286046 0.86 LMNA (0.40) LMNAHPGDKMT2AMEN1SMN1; SMN2
Hydrogen Sulfide SCHEMBL28313413 0.86 LMNA (0.39) LMNAHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL25250816 0.86 LMNA (0.39) LMNAHPGDKMT2AMEN1SMN1; SMN2
Lithium SCHEMBL30307090 0.86 LMNA (0.39) LMNAHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL30988127 0.86 KMT2A (0.41) LMNAHPGDKMT2AMEN1SMN1; SMN2
Iodide SCHEMBL29831346 0.86 LMNA (0.39) LMNAHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL7635001 0.85 LMNA (0.45) LMNATSHRHPGDGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105907138-B Hard coating composition and hard coating film using the same 东友精细化工有限公司 2021-03-05 CN claimed
CN-122080333-A Curable composition, heat storage material, and article 2026-05-26 CN disclosed
WO-2026105802-A1 RESIN COMPOSITION, DRY FILM, AND CURED PRODUCT 太陽ホールディングス株式会社 2026-05-21 WO disclosed
US-12624140-B2 Composition containing compound having polyoxyalkylene chain RESONAC CORPORATION (JP) 2026-05-12 US disclosed
CN-122011299-A Curable composition, heat storage material, and article 株式会社力森诺科 2026-05-12 CN disclosed
EP-4711396-A1 CURABLE COMPOSITION Tokyo University of Science (JP) 2026-03-18 EP disclosed
US-12492275-B2 Photo-curable compositions containing high refractive index monomers for use in 3D printing applications ARKEMA FRANCE (FR) 2025-12-09 US disclosed
US-20250346702-A1 COMPOSITION THAT CONTAINS COMPOUND HAVING POLYOXYALKYLENE CHAIN AND ACRYLIC COPOLYMER RESONAC CORP (JP) 2025-11-13 US disclosed
US-20250304748-A1 RESIN COMPOSITION, DRY FILM, AND CURED PRODUCT TAIYO HOLDINGS CO., LTD. (JP) 2025-10-02 US disclosed
US-20250297092-A1 COMPOSITION THAT CONTAINS COMPOUND HAVING POLYOXYALKYLENE CHAIN AND ESTER-BASED THIXOTROPY-IMPARTING AGENT RESONAC CORPORATION (JP) 2025-09-25 US disclosed
US-20110070434-A1 ACRYLIC PRESSURE-SENSITIVE ADHESIVE, ACRYLIC PRESSURE-SENSITIVE ADHESIVE LAYER AND ACRYLIC PRESSURE-SENSITIVE ADHESIVE TAPE OR SHEET NITTO DENKO CORPORATION (JP) 2011-03-24 US disclosed
EP-2256174-A1 ACRYLIC ADHESIVE, ACRYLIC ADHESIVE LAYER, AND ACRYLIC ADHESIVE TAPE OR SHEET Nitto Denko Corporation (JP) 2010-12-01 EP disclosed
US-20100196704-A1 COMPOSITE FILM NITTO DENKO CORPORATION (JP) 2010-08-05 US disclosed
EP-2186849-A1 COMPOSITE FILM Nitto Denko Corporation (JP) 2010-05-19 EP disclosed
US-20050096406-A1 Reactive diluents and alkyd resin coating compositions PRETOT ROGER (CH) 2005-05-05 US disclosed
US-20020042022-A1 Alkylphenylbisacylphosphine oxides and photoinitiator mixtures LEPPARD DAVID GEORGE (CH) 2002-04-11 US disclosed
US-6361925-B1 WHICH ARE CAPABLE OF CURING PHOTOPOLYMERIZABLE COMPOSITIONS EFFICIENTLY AND WITHOUT EXTREME YELLOWING CIBA SPECIALTY CHEMICALS CORPORATION 2002-03-26 US disclosed
US-6284813-B1 MIXTURES WITH BENZOYL COMPOUNDS SUCH AS 1-BENZOYLCYCLOHEXANOL OR 1-BENZOYL-1-HYDROXY-1-METHYLETHANE CIBA SPECIALTY CHEMICALS CORP. 2001-09-04 US disclosed
US-6020528-A Alkylphenylbisacylphosphine oxides and photoinitiator mixtures CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-02-01 US disclosed
US-5534559-A UNSATURATED POLYESTERS CIBA-GEIGY CORPORATION (US) 1996-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624140-B2 Composition containing compound having polyoxyalkylene chain PIEZO1, HVCN1, TAF11 LMNA 1150/4885TSHR 3431/4885HPGD 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.